PL3930838T3 - Pochodne n-(pirydynylo)acetamidu jako inhibitory hat p300/cbp oraz sposoby ich zastosowania - Google Patents

Pochodne n-(pirydynylo)acetamidu jako inhibitory hat p300/cbp oraz sposoby ich zastosowania

Info

Publication number
PL3930838T3
PL3930838T3 PL20714389.2T PL20714389T PL3930838T3 PL 3930838 T3 PL3930838 T3 PL 3930838T3 PL 20714389 T PL20714389 T PL 20714389T PL 3930838 T3 PL3930838 T3 PL 3930838T3
Authority
PL
Poland
Prior art keywords
pyridinyl
methods
acetamide derivatives
cbp hat
hat inhibitors
Prior art date
Application number
PL20714389.2T
Other languages
English (en)
Inventor
Jonathan E. Wilson
Original Assignee
Constellation Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Constellation Pharmaceuticals, Inc. filed Critical Constellation Pharmaceuticals, Inc.
Publication of PL3930838T3 publication Critical patent/PL3930838T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL20714389.2T 2019-02-27 2020-02-26 Pochodne n-(pirydynylo)acetamidu jako inhibitory hat p300/cbp oraz sposoby ich zastosowania PL3930838T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962811143P 2019-02-27 2019-02-27
US201962879852P 2019-07-29 2019-07-29
PCT/US2020/019786 WO2020176558A1 (en) 2019-02-27 2020-02-26 P300/cbp hat inhibitors and methods for their use

Publications (1)

Publication Number Publication Date
PL3930838T3 true PL3930838T3 (pl) 2024-12-02

Family

ID=70005771

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20714389.2T PL3930838T3 (pl) 2019-02-27 2020-02-26 Pochodne n-(pirydynylo)acetamidu jako inhibitory hat p300/cbp oraz sposoby ich zastosowania

Country Status (19)

Country Link
US (1) US20220135538A1 (pl)
EP (1) EP3930838B1 (pl)
JP (1) JP7638880B2 (pl)
CN (1) CN113727756B (pl)
AU (1) AU2020227742A1 (pl)
CA (1) CA3131383A1 (pl)
DK (1) DK3930838T3 (pl)
ES (1) ES2989353T3 (pl)
FI (1) FI3930838T3 (pl)
HR (1) HRP20241237T1 (pl)
HU (1) HUE068415T2 (pl)
LT (1) LT3930838T (pl)
PL (1) PL3930838T3 (pl)
PT (1) PT3930838T (pl)
RS (1) RS65998B1 (pl)
SI (1) SI3930838T1 (pl)
SM (1) SMT202400386T1 (pl)
TW (1) TWI850342B (pl)
WO (1) WO2020176558A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240122941A1 (en) * 2020-12-25 2024-04-18 National Cancer Center Therapy based on synthetic lethality in swi/snf complex-dysfunction cancer
WO2025169375A1 (ja) 2024-02-07 2025-08-14 住友ファーマ株式会社 4員環構造で置換された3級アミド誘導体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014014767A2 (pt) 2011-12-16 2017-06-13 Olema Pharmaceuticals Inc novos compostos de benzopirano, composições e usos dos mesmos
US20160235716A1 (en) 2014-09-18 2016-08-18 Abbvie Inc. Spirocyclic hat inhibitors and methods for their use
CN107108512B (zh) 2014-10-10 2021-05-04 基因泰克公司 治疗性化合物及其用途
EP3632915A1 (en) * 2014-11-27 2020-04-08 Genentech, Inc. 4,5,6,7-tetrahydro-1 h-pyrazolo[4,3-c]pyridin-3-amine compounds as cbp and/or ep300 inhibitors
EP3302468A4 (en) * 2015-06-01 2019-02-06 The Scripps Research Institute SMALL MOLECULAR ANALOGS OF NEMO BINDING PEPTIDE
WO2017205536A2 (en) * 2016-05-24 2017-11-30 Genentech, Inc. Therapeutic compounds and uses thereof
MA45146A (fr) * 2016-05-24 2021-03-24 Constellation Pharmaceuticals Inc Dérivés de pyrazolopyridine pour le traitement du cancer
EP3643703A4 (en) 2017-06-21 2020-12-23 Daiichi Sankyo Co., Ltd. EP300 / CREBBP INHIBITOR
UY37866A (es) * 2017-09-07 2019-03-29 Glaxosmithkline Ip Dev Ltd Nuevos compuestos derivados de benzoimidazol sustituidos que reducen la proteína myc (c-myc) en las células e inhiben la histona acetiltransferasa de p300/cbp.
AU2019220662B2 (en) * 2018-02-16 2024-06-13 Constellation Pharmaceuticals, Inc. P300/CBP HAT inhibitors

Also Published As

Publication number Publication date
PT3930838T (pt) 2024-10-04
JP2022522349A (ja) 2022-04-18
FI3930838T3 (fi) 2024-10-14
EP3930838A1 (en) 2022-01-05
HUE068415T2 (hu) 2024-12-28
LT3930838T (lt) 2024-09-10
CN113727756A (zh) 2021-11-30
JP7638880B2 (ja) 2025-03-04
DK3930838T3 (da) 2024-10-07
SMT202400386T1 (it) 2024-11-15
US20220135538A1 (en) 2022-05-05
EP3930838B1 (en) 2024-07-10
WO2020176558A1 (en) 2020-09-03
CA3131383A1 (en) 2020-09-03
TW202045492A (zh) 2020-12-16
CN113727756B (zh) 2024-07-02
HRP20241237T1 (hr) 2024-12-06
TWI850342B (zh) 2024-08-01
AU2020227742A1 (en) 2021-09-16
SI3930838T1 (sl) 2024-10-30
RS65998B1 (sr) 2024-10-31
ES2989353T3 (es) 2024-11-26

Similar Documents

Publication Publication Date Title
IL282099B (en) N-(phenylsulfonyl)benzamides and related compounds as bcl–2 inhibitors
ZA202100644B (en) Kras g12c inhibitors and methods of using the same
IL272512A (en) Inhibitors of kras g12c and methods of using the same
SG10201913464TA (en) Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof
ZA202000727B (en) New heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and 2 (hdac1-2)
ZA202407941B (en) Arginase inhibitors and methods of use thereof
PT3752497T (pt) Inibidores de p300/cbp hat
IL288381A (en) Tead inhibitors and their uses
IL313636A (en) Compounds and their use as HDAC6 inhibitors
IL280924A (en) Arginase inhibitors and methods of using them
HUE068415T2 (hu) N-(piridinil)acetamid származékok mint P300/CBP HAT gátlók és eljárások alkalmazásukra
ZA202105833B (en) Arginase inhibitors and methods of use thereof
HK40042247A (en) Cyano quinoline amide compounds as her2 inhibitors and methods of use